Molecular and epigenetic characterization and study of tetraploidies in drug-resistant epileptic patients of the temporal lobe

Funding period: 2018-2021

Funding Agency: Proyecto de Investigación en Salud Instituto de Salud Carlos III

Principal Investigator: Dr. Mª Carmen Ovejero Benito y Dr. Cristina Torres

Pharmacogenetics of Brodalumab

Funding period: 2019-2022

Funding Agency: Leo Pharma

Principal Investigator: Mª Carmen Ovejero Benito